Drug and Device Makers Must Disclose Payments to Patient Advocacy Groups.
This law mandates that pharmaceutical and medical device manufacturers publicly disclose all payments and donations made to patient advocacy organizations. This increased transparency allows citizens to better understand the funding sources of groups representing their interests, helping them evaluate potential conflicts of interest or biases in the information provided. The goal is to enhance public trust in patient support services.
Key points
Drug and device manufacturers are required to publicly report all financial transfers to patient advocacy organizations.
This disclosure covers both direct payments and indirect payments channeled through third parties if the manufacturer directs the transfer.
The public will gain access to information about who funds patient support groups, promoting greater accountability.
Expired
Citizen Poll